COMMUNIQUÉS West-GlobeNewswire

Beghou Consulting Prepares for Next Phase of Growth, Names Adrienne Lovink, Chief Services Officer, to Succeed Beth Beghou, Founder and CEO

23/04/2025 - 14:00

Adrienne Lovink to build on three decades of Beth Beghou’s transformative legacy, with a focus on maintaining best-in-class commercialization solutions while expanding technology- and AI-enabled capabilities EVANSTON, [...]

Rhythm Pharmaceuticals to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

23/04/2025 - 14:00

BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]

Codetta Bio to Launch Concerto™ System at AACR 2025 with Exhibitor Spotlight Presentation

23/04/2025 - 14:00

DURHAM, N.C., April 23, 2025 (GLOBE NEWSWIRE) -- Codetta Bio , a leader in multi-omics innovation, today announced its presence at the American Association for Cancer Research (AACR) Annual Meeting 2025, where the [...]

Recce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot Infections

23/04/2025 - 14:00

Human Research Ethics Committee (HREC) approval received to allow up to 20 additional patients access to RECCE ® 327 Topical Gel (R327G) treatment under existing open-label study protocol Program enables access to R327G [...]

Catheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart Failure

23/04/2025 - 14:00

Initial Clinical Studies Completed with Significant Positive Results The Cleveland Clinic Foundation, Abbott Laboratories and a New Era Associates (NEA) fund to Acquire Economic Interests in VTAK Fort Mill, S.C., April [...]

UNITY Biotechnology Announces Publication in NEJM Evidence Highlighting the Potential of Senolytic Therapeutics to Provide Long-Term Improvements in Vision in DME

23/04/2025 - 14:00

SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today [...]

Plus Therapeutics Announces Biotech Industry Veteran Kyle Guse Joins its Board of Directors

23/04/2025 - 14:00

HOUSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for [...]

Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore

23/04/2025 - 14:00

The STCC Unified PD1/PDL1 Evaluation of Response (SUPER) study is a multi-institutional study led by STCC with the goal of identifying predictors of PD1 immunotherapy response in an Asian real-world setting, bringing [...]

Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025

23/04/2025 - 14:00

FORT WORTH, TX, April 23, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to [...]

Sagimet Biosciences Announces Upcoming Presentations at EASL Congress 2025

23/04/2025 - 14:00

SAN MATEO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and [...]

Protara Therapeutics to Host Conference Call and Webcast to Review Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC on Monday, April 28, 2025

23/04/2025 - 14:00

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced it will [...]

Daré Bioscience to Present at the Fierce Pharma Engage Summit on Breaking Barriers and Building Access: Communicating Bold Moves in Women’s Health Innovation

23/04/2025 - 14:00

Presentation will focus on corporate communications strategies for unveiling an innovative expanded business strategy Daré recently announced its new dual-path approach for its proprietary Sildenafil Cream formulation [...]

Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025

23/04/2025 - 14:00

BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company pioneering positive functional modulators (PFMs) that restore and enhance membrane protein function, today [...]

Arialief Reviews And Complaints (INVESTIGATIVE REPORT) Safe Ingredients for Neuropathy Relief or Over Hype?

23/04/2025 - 14:00

MIAMI, April 23, 2025 (GLOBE NEWSWIRE) -- Arialief is a nerve-support supplement that has recently seen a rise in popularity. Like many dietary supplements aimed at relieving sciatic discomfort, it claims to deliver [...]

Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025

23/04/2025 - 14:00

• Management to host conference call on Thursday, May 1, 2025, at 8:00 am EDT FLORHAM PARK, N.J., April 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on [...]

ProDentim Complaints & Side Effects (EXPOSED) Investigative Consumer Report Examines Scientific Claims About ProDentim!

23/04/2025 - 05:55

AUSTIN, Texas, April 22, 2025 (GLOBE NEWSWIRE) -- ProDentim is a dental probiotic formula that fosters healthy teeth and gums by building a balanced ecosystem within the mouth. It addresses the root cause of oral [...]

Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancers

23/04/2025 - 09:00

INGELHEIM, Germany and AMSTERDAM, April 23, 2025 (GLOBE NEWSWIRE) -- Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have entered [...]

Cytovation Raises US$6m to Advance Phase 2 Development of CY-101 in Adrenocortical Carcinoma to First Clinical Readouts

23/04/2025 - 09:00

New funds provided largely by existing investors, led by Sandwater Phase 2 trial to be delivered through novel agreement between Cytovation, Cancer Research UK and the Norwegian Cancer Society New preclinical data [...]

Antag Therapeutics expands senior team to support clinical progress

23/04/2025 - 09:00

Copenhagen, Denmark, 23 April 2025 – Antag Therapeutics (“Antag” or “the Company”), a biopharmaceutical company pioneering novel treatments for obesity, today announces the appointment of three new hires to support the [...]